Velos acquired by WCG, a portfolio company of Arsenal Capital Partners

December 17, 2018

Overview

WIRB-Copernicus Group (WCG), the leading provider of tech-enabled solutions that improve the quality and efficiency of clinical research, announced its acquisition of Velos.

Velos offers a Clinical Trial Management System (CTMS) software platform with automated research review and biospecimen management solutions that facilitates trial administration, financial and regulatory management, patient tracking, reporting, and other facets of clinical research.

Significance

The acquisition expands and enhances WCG’s clinical trial management capabilities for site support and management, patient engagement, and scientific, regulatory, biosafety and ethical review.

Crosstree’s Role

Crosstree Capital Partners acted as the exclusive financial advisor to Velos.

Velos acquired by WCG, a portfolio company of Arsenal Capital Partners